Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sensi

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Clinical Chemistry|March 1, 1989
D-lysine effectively decreases the non-enzymic glycation of proteins in vitroM Sensi, F Pricci, M G De Rossi, et al.
Melanoma Research|November 1, 1991
Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene familiesM Sensi, C Castelli, A Anichini, et al.
Diabetologia|July 1, 1984
Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetesP Pozzilli, M Sensi, L Al-Sakkaf, et al.
Diabetologia|February 1, 1985
Sera from diabetic pregnant women contain reduced titres of inhibiting factors on killer cell activityO Zuccarini, M Sensi, P Gargiulo, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1985
In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetesM Sensi, O Zuccarini, K M Spencer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell cloneA Mazzocchi, A Anichini, C Castelli, et al.
Diabetes Research (Edinburgh, Scotland)|April 1, 1990
Retinol binding protein: a short half life determinant of protein non enzymatic glycation in diabetesM Sensi, M R Bruno, L Valente, et al.
Cancer Research|September 1, 1994
Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogeneC Castelli, M Sensi, R Lupetti, et al.
Clinical and Experimental Immunology|February 1, 1985
Activated T cells in Graves' disease before treatmentR Kennedy, U Di Mario, P Pozzilli, et al.
Journal of Endocrinological Investigation|July 2, 2008
Immunogenicity of advanced glycation end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantationA M Buongiorno, S Morelli, E Sagratella, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Clinical Chemistry|March 1, 1989
D-lysine effectively decreases the non-enzymic glycation of proteins in vitroM Sensi, F Pricci, M G De Rossi, et al.
Melanoma Research|November 1, 1991
Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene familiesM Sensi, C Castelli, A Anichini, et al.
Diabetologia|July 1, 1984
Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetesP Pozzilli, M Sensi, L Al-Sakkaf, et al.
Diabetologia|February 1, 1985
Sera from diabetic pregnant women contain reduced titres of inhibiting factors on killer cell activityO Zuccarini, M Sensi, P Gargiulo, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1985
In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetesM Sensi, O Zuccarini, K M Spencer, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell cloneA Mazzocchi, A Anichini, C Castelli, et al.
Diabetes Research (Edinburgh, Scotland)|April 1, 1990
Retinol binding protein: a short half life determinant of protein non enzymatic glycation in diabetesM Sensi, M R Bruno, L Valente, et al.
Cancer Research|September 1, 1994
Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogeneC Castelli, M Sensi, R Lupetti, et al.
Clinical and Experimental Immunology|February 1, 1985
Activated T cells in Graves' disease before treatmentR Kennedy, U Di Mario, P Pozzilli, et al.
Journal of Endocrinological Investigation|July 2, 2008
Immunogenicity of advanced glycation end products in diabetic patients and in nephropathic non-diabetic patients on hemodialysis or after renal transplantationA M Buongiorno, S Morelli, E Sagratella, et al.
Pageof 11